New spine device aims to straighten Kids' curves without repeat surgeries

NCT ID NCT02266667

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 29 times

Summary

This study tested a device called NEMOST, which is implanted in the spine of children with progressive scoliosis. The goal was to see if the device, combined with physiotherapy, could keep the spine straight while allowing natural growth and avoiding the need for more surgeries. Twenty children aged 5 to 15 took part, and the main measure of success was no worsening of the spine curve by more than 15 degrees one year after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROGRESSIVE SCOLIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Necker Enfants Malades

    Paris, 75015, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

NEMOST growing spine device (implanted rods) plus physiotherapy

What this could lead to

If successful, this device could help children with progressive scoliosis avoid multiple surgeries while maintaining spine correction and natural growth.

What could go wrong

This is a small, early study with only 20 participants, so results may not apply to all children. The device may fail to prevent curve worsening or could require reoperation.

Conditions

The condition(s) this trial relates to.

scoliosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.